Build Your Comparison

Side-by-side financial analysis
FLGC logo
FLGC
DBVT logo
DBVT
JPM logo
JPM
BAC logo
BAC
ALKS logo
ALKS
KO logo
KO
Try popular comparisons:

Stock Comparison

FLGC vs DBVT vs JPM vs BAC vs ALKS vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FLGC
Flora Growth Corp.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$88M
5Y Perf.-99.8%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$919M
5Y Perf.-64.1%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$908.57B
5Y Perf.+82.8%
BAC
Bank of America Corporation

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$424.14B
5Y Perf.+17.6%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$7.50B
5Y Perf.+32.8%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$341.71B
5Y Perf.+47.5%

FLGC vs DBVT vs JPM vs BAC vs ALKS vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FLGC logoFLGC
DBVT logoDBVT
JPM logoJPM
BAC logoBAC
ALKS logoALKS
KO logoKO
IndustryDrug Manufacturers - Specialty & GenericBiotechnologyBanks - DiversifiedBanks - DiversifiedBiotechnologyBeverages - Non-Alcoholic
Market Cap$88M$919M$908.57B$424.14B$7.50B$341.71B
Revenue (TTM)$14M$0.00$280.33B$191.57B$1.56B$49.28B
Net Income (TTM)$-120M$-168M$57.05B$30.51B$153M$13.70B
Gross Margin43.3%60.0%56.1%65.4%61.7%
Operating Margin-30.7%25.9%19.7%12.3%29.3%
Forward P/E14.6x12.6x31.5x24.3x
Total Debt$54M$22M$942.38B$365.90B$70M$45.49B
Cash & Equiv.$6M$194M$343.34B$231.84B$1.12B$10.27B

FLGC vs DBVT vs JPM vs BAC vs ALKS vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FLGC
DBVT
JPM
BAC
ALKS
KO
StockMay 21Mar 26Return
Flora Growth Corp. (FLGC)1000.2-99.8%
DBV Technologies S.… (DBVT)10035.9-64.1%
JPMorgan Chase & Co. (JPM)100182.8+82.8%
Bank of America Cor… (BAC)100117.6+17.6%
Alkermes plc (ALKS)100132.8+32.8%
The Coca-Cola Compa… (KO)100147.5+47.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: FLGC vs DBVT vs JPM vs BAC vs ALKS vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: KO leads in 3 of 7 categories (6-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. Bank of America Corporation is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. DBVT and JPM also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇KO emerged as the overall leader. Track its performance:
FLGC
Flora Growth Corp.
The Healthcare Pick

Among these 6 stocks, FLGC doesn't own a clear edge in any measured category.

Best for: healthcare exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT ranks third and is worth considering specifically for momentum.

  • +57.7% vs FLGC's -74.3%
Best for: momentum
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is long-term compounding and bank quality.

  • 481.2% 10Y total return vs BAC's 371.6%
  • NIM 2.2% vs BAC's 1.8%
  • 3.3% NII/revenue growth vs DBVT's -100.0%
Best for: long-term compounding and bank quality
BAC
Bank of America Corporation
The Banking Pick

BAC is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.

  • Dividend streak 12 yrs, beta 0.83, yield 2.3%
  • PEG 0.82 vs KO's 2.17
  • Beta 0.83, yield 2.3%, current ratio 0.42x
  • Lower P/E (12.6x vs 24.3x), PEG 0.82 vs 2.17
Best for: income & stability and valuation efficiency
ALKS
Alkermes plc
The Defensive Pick

ALKS is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.88, Low D/E 3.8%, current ratio 3.55x
Best for: sleep-well-at-night
KO
The Coca-Cola Company
The Growth Play

KO carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 1.9%, EPS growth 23.6%, 3Y rev CAGR 3.7%
  • 27.8% margin vs FLGC's -8.3%
  • 2.6% yield, 56-year raise streak, vs JPM's 1.8%, (3 stocks pay no dividend)
  • 13.1% ROA vs FLGC's -192.1%, ROIC 15.8% vs -5.5%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthJPM logoJPM3.3% NII/revenue growth vs DBVT's -100.0%
ValueBAC logoBACLower P/E (12.6x vs 24.3x), PEG 0.82 vs 2.17
Quality / MarginsKO logoKO27.8% margin vs FLGC's -8.3%
Stability / SafetyBAC logoBACBeta 0.83 vs FLGC's 3.12
DividendsKO logoKO2.6% yield, 56-year raise streak, vs JPM's 1.8%, (3 stocks pay no dividend)
Momentum (1Y)DBVT logoDBVT+57.7% vs FLGC's -74.3%
Efficiency (ROA)KO logoKO13.1% ROA vs FLGC's -192.1%, ROIC 15.8% vs -5.5%

FLGC vs DBVT vs JPM vs BAC vs ALKS vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FLGCFlora Growth Corp.
FY 2021
Pharmaceuticals and Nutraceuticals
100.0%$2M
DBVTDBV Technologies S.A.

Segment breakdown not available.

JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
BACBank of America Corporation
FY 2024
Loans and Leases
32.2%$62.0B
other interest income
14.7%$28.3B
Debt securities
13.5%$26.0B
Federal funds sold and securities borrowed or purchased under agreements to resell
10.3%$19.9B
Investment And Brokerage Services
9.2%$17.8B
Market making and similar activities
6.7%$13.0B
Trading account assets
5.4%$10.4B
Other (4)
7.8%$15.1B
ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

FLGC vs DBVT vs JPM vs BAC vs ALKS vs KO — Financial Metrics

Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGBAC

Income & Cash Flow (Last 12 Months)

Evenly matched — ALKS and KO each lead in 2 of 6 comparable metrics.

JPM and DBVT operate at a comparable scale, with $280.3B and $0 in trailing revenue. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to FLGC's -8.3%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFLGC logoFLGCFlora Growth Corp.DBVT logoDBVTDBV Technologies …JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…ALKS logoALKSAlkermes plcKO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$14M$0$280.3B$191.6B$1.6B$49.3B
EBITDAEarnings before interest/tax-$4M-$112M$81.4B$40.0B$212M$15.5B
Net IncomeAfter-tax profit-$120M-$168M$57.0B$30.5B$153M$13.7B
Free Cash FlowCash after capex-$9M-$151M$100.9B$12.6B$392M$12.6B
Gross MarginGross profit ÷ Revenue+43.3%+60.0%+56.1%+65.4%+61.7%
Operating MarginEBIT ÷ Revenue-30.7%+25.9%+19.7%+12.3%+29.3%
Net MarginNet income ÷ Revenue-8.3%+20.4%+15.9%+9.8%+27.8%
FCF MarginFCF ÷ Revenue-63.5%+36.0%+6.6%+25.1%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year-2.6%+28.2%+12.1%
EPS Growth (YoY)Latest quarter vs prior year+2.6%+91.5%+16.0%+18.3%-4.1%+18.2%
Evenly matched — ALKS and KO each lead in 2 of 6 comparable metrics.

Valuation Metrics

Evenly matched — FLGC and JPM and BAC each lead in 2 of 7 comparable metrics.

At 14.7x trailing earnings, BAC trades at a 53% valuation discount to ALKS's 31.5x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.92x vs KO's 2.34x — a lower PEG means you pay less per unit of expected earnings growth.

MetricFLGC logoFLGCFlora Growth Corp.DBVT logoDBVTDBV Technologies …JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…ALKS logoALKSAlkermes plcKO logoKOThe Coca-Cola Com…
Market CapShares × price$88M$919M$908.6B$424.1B$7.5B$341.7B
Enterprise ValueMkt cap + debt − cash$87M$747M$1.51T$558.2B$6.4B$376.9B
Trailing P/EPrice ÷ TTM EPS-5.55x-0.59x16.22x14.71x31.46x26.12x
Forward P/EPrice ÷ next-FY EPS est.14.60x12.60x24.27x
PEG RatioP/E ÷ EPS growth rate0.92x0.96x2.34x
EV / EBITDAEnterprise value multiple18.52x13.95x22.94x25.45x
Price / SalesMarket cap ÷ Revenue1.49x3.25x2.21x5.08x7.13x
Price / BookPrice ÷ Book value/share19.61x0.51x2.51x1.40x4.17x9.99x
Price / FCFMarket cap ÷ FCF9.01x33.63x15.61x64.52x
Evenly matched — FLGC and JPM and BAC each lead in 2 of 7 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-3 for FLGC. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs FLGC's 3/9, reflecting strong financial health.

MetricFLGC logoFLGCFlora Growth Corp.DBVT logoDBVTDBV Technologies …JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…ALKS logoALKSAlkermes plcKO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity-3.3%-130.2%+15.9%+10.1%+8.8%+41.1%
ROA (TTM)Return on assets-192.1%-89.0%+1.3%+0.9%+5.4%+13.1%
ROICReturn on invested capital-5.5%+4.5%+3.5%+18.9%+15.8%
ROCEReturn on capital employed-6.9%-145.7%+8.9%+4.5%+14.2%+17.3%
Piotroski ScoreFundamental quality 0–9345777
Debt / EquityFinancial leverage0.76x0.13x2.60x1.21x0.04x1.33x
Net DebtTotal debt minus cash$48M-$172M$599.0B$134.1B-$1.0B$35.2B
Cash & Equiv.Liquid assets$6M$194M$343.3B$231.8B$1.1B$10.3B
Total DebtShort + long-term debt$54M$22M$942.4B$365.9B$70M$45.5B
Interest CoverageEBIT ÷ Interest expense-18.87x-189.82x0.74x0.48x32.30x10.70x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $25 for FLGC. Over the past 12 months, DBVT leads with a +57.7% total return vs FLGC's -74.3%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs FLGC's -62.9% — a key indicator of consistent wealth creation.

MetricFLGC logoFLGCFlora Growth Corp.DBVT logoDBVTDBV Technologies …JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…ALKS logoALKSAlkermes plcKO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date+5.3%-18.5%+0.8%+1.4%+59.2%+16.4%
1-Year ReturnPast 12 months-74.3%+57.7%+20.9%+27.2%+53.4%+17.7%
3-Year ReturnCumulative with dividends-94.9%-24.6%+138.8%+105.5%+38.7%+39.3%
5-Year ReturnCumulative with dividends-99.8%-74.4%+135.5%+57.4%+84.2%+65.3%
10-Year ReturnCumulative with dividends-99.8%-89.9%+481.2%+371.6%+7.4%+115.0%
CAGR (3Y)Annualised 3-year return-62.9%-9.0%+33.7%+27.1%+11.5%+11.7%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ALKS and KO each lead in 1 of 2 comparable metrics.

KO is the less volatile stock with a -0.23 beta — it tends to amplify market swings less than FLGC's 3.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 98.3% from its 52-week high vs FLGC's 15.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFLGC logoFLGCFlora Growth Corp.DBVT logoDBVTDBV Technologies …JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…ALKS logoALKSAlkermes plcKO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5003.12x1.12x0.87x0.83x0.88x-0.23x
52-Week HighHighest price in past year$47.00$26.18$338.09$57.98$45.76$84.04
52-Week LowLowest price in past year$5.86$8.50$269.72$44.21$25.17$65.35
% of 52W HighCurrent price vs 52-week peak+15.3%+59.3%+96.2%+96.9%+98.3%+94.5%
RSI (14)Momentum oscillator 0–10047.137.572.170.969.549.2
Avg Volume (50D)Average daily shares traded11K225K7.4M32.4M1.9M13.6M
Evenly matched — ALKS and KO each lead in 1 of 2 comparable metrics.

Analyst Outlook

KO leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: DBVT as "Buy", JPM as "Buy", BAC as "Buy", ALKS as "Buy", KO as "Buy". Consensus price targets imply 198.3% upside for DBVT (target: $46) vs 4.5% for JPM (target: $340). For income investors, KO offers the higher dividend yield at 2.56% vs JPM's 1.83%.

MetricFLGC logoFLGCFlora Growth Corp.DBVT logoDBVTDBV Technologies …JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…ALKS logoALKSAlkermes plcKO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$46.33$339.75$61.13$49.50$86.13
# AnalystsCovering analysts1561542848
Dividend YieldAnnual dividend ÷ price+1.8%+2.3%+2.6%
Dividend StreakConsecutive years of raises01512056
Dividend / ShareAnnual DPS$5.95$1.27$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+3.8%+5.1%+0.4%+0.2%
KO leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

ALKS leads in 1 of 6 categories (Profitability & Efficiency). JPM leads in 1 (Total Returns). 3 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 1 of 6 categories
Loading custom metrics...

FLGC vs DBVT vs JPM vs BAC vs ALKS vs KO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FLGC or DBVT or JPM or BAC or ALKS or KO a better buy right now?

For growth investors, JPMorgan Chase & Co.

(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -75. 6% for Flora Growth Corp. (FLGC). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FLGC or DBVT or JPM or BAC or ALKS or KO?

On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.

7x versus Alkermes plc at 31. 5x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank of America Corporation wins at 0. 82x versus The Coca-Cola Company's 2. 17x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — FLGC or DBVT or JPM or BAC or ALKS or KO?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +135. 5%, compared to -99. 8% for Flora Growth Corp. (FLGC). Over 10 years, the gap is even starker: JPM returned +481. 2% versus FLGC's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FLGC or DBVT or JPM or BAC or ALKS or KO?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

23β versus Flora Growth Corp. 's 3. 12β — meaning FLGC is approximately -1435% more volatile than KO relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FLGC or DBVT or JPM or BAC or ALKS or KO?

By revenue growth (latest reported year), JPMorgan Chase & Co.

(JPM) is pulling ahead at 3. 3% versus -75. 6% for Flora Growth Corp. (FLGC). On earnings-per-share growth, the picture is similar: Flora Growth Corp. grew EPS 100. 0% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FLGC or DBVT or JPM or BAC or ALKS or KO?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -30. 5% for Flora Growth Corp. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -30. 7% for FLGC. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FLGC or DBVT or JPM or BAC or ALKS or KO more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Bank of America Corporation (BAC) is the more undervalued stock at a PEG of 0. 82x versus The Coca-Cola Company's 2. 17x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 6x forward P/E versus 24. 3x for The Coca-Cola Company — 11. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 198. 3% to $46. 33.

08

Which pays a better dividend — FLGC or DBVT or JPM or BAC or ALKS or KO?

In this comparison, KO (2.

6% yield), BAC (2. 3% yield), JPM (1. 8% yield) pay a dividend. FLGC, DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is FLGC or DBVT or JPM or BAC or ALKS or KO better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

23), 2. 6% yield, +115. 0% 10Y return). Flora Growth Corp. (FLGC) carries a higher beta of 3. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +115. 0%, FLGC: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FLGC and DBVT and JPM and BAC and ALKS and KO?

These companies operate in different sectors (FLGC (Healthcare) and DBVT (Healthcare) and JPM (Financial Services) and BAC (Financial Services) and ALKS (Healthcare) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FLGC is a small-cap quality compounder stock; DBVT is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; ALKS is a small-cap quality compounder stock; KO is a large-cap quality compounder stock. JPM, BAC, KO pay a dividend while FLGC, DBVT, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.